Minireview: Nanoparticles for molecular imaging - An overview

Endocrinology

Volumn 151, Issue 2, 2010, Pages 474-481

  Minchin, Rodney F ^a   Martin, Darren J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

CHRONIC TOXICITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FLUORESCENCE; LUMINESCENCE; MOLECULAR IMAGING; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; RETICULOENDOTHELIAL SYSTEM; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; HUMAN; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; DIAGNOSTIC IMAGING; FLUORESCENCE; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NANOPARTICLES; NANOTECHNOLOGY; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 74949103873     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1012     Document Type: Short Survey

References (61)

1. Massoud TF, Gambhir SS 2003 Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545-580
2. Wiwanitkit V 2006 Glomerular pore size corresponding to albumin molecular size, an explanation for underlying structural pathology leading to albuminuria at nanolevel. Renal Fail 28:101
3. CaiW,ChenX2007 Nanoplatforms for targeted molecular imaging in living subjects. Small 3:1840-1854
4. Caruthers SD, Wickline SA, Lanza GM 2007 Nanotechnological applications in medicine. Curr Opin Biotechnol 18:26-30
5. Debbage P, JaschkeW2008 Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochem Cell Biol 130:845-875
6. Douma K, Prinzen L, Slaaf DW, Reutelingsperger CP, Biessen EA, Hackeng TM, Post MJ, van ZandvoortMA2009 Nanoparticles for optical molecular imaging of atherosclerosis. Small 5:544-557
7. Ullman EF, Schwarzberg M, Rubenstein KE 1976 Fluorescent excitation transfer immunoassay. A general method for determination of antigens. J Biol Chem 251:4172-4178
8. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St. Pierre TG, SaundersM2003 Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 15:1367-1377
9. Sato N, Kobayashi H, Hiraga A, Saga T, Togashi K, Konishi J, BrechbielMW2001 Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 46:1169-1173
10. Gö hr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J 1993 The demonstration of human tumors on nude mice using gadoliniumlabelled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 28:789-795
11. Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA 2004 Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51:480 -486
12. Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ 2000 Magnetic resonance contrast enhancement of neovasculature with α(v)β(3)-targeted nanoparticles. Magn Reson Med 44:433-439
13. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM 2003 Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 50:411-416
14. van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG 2009 Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci USA 106:18-23
15. Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ 2005 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J Nucl Med 46:1210-1218
16. Choi H, Choi SR, Zhou R, Kung HF, Chen IW 2004 Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996-1004
17. Chen TJ, Cheng TH, Hung YC, Lin KT, Liu GC, Wang YM 2008 Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI. J Biomed Mater Res 87:165-175
18. Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A 2007 Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles. J Controlled Release 124:28-34
19. Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, LanzaGM2008 Three-dimensionalMRmapping of angiogenesis with α5β1(ανβ3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. FASEB J 22: 4179-4189
20. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, Löwik CW, Kaijzel EL, Que I, Storm G, Strijkers GJ, GriffioenAW,NicolayK2009 Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots. Angiogenesis 12:17-24
21. Jennings LE, Long NJ 2009 'Two is better than one'-probes for dualmodality molecular imaging. Chem Commun (Camb):3511-3524
22. Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, Strijkers GJ, de Mello Donegá C, Nicolay K, Griffioen AW 2006 Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 6:1-6
23. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, Olson J, Zhang M 2005 Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 5:1003-1008
24. Diagaradjane P, Orenstein-Cardona JM, Coló n-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, Schwartz DL, Gelovani JG, Krishnan S 2008 Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 14: 731-741
25. Yaghoubi S, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, Goldman R, HerschmanHR,PhelpsME,Gambhir SS 2001 Human pharmacokinetic and dosimetry studies of [18F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42:1225-1234
26. Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD 2001 Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727-729
27. Rao J, Dragulescu-Andrasi A, YaoH 2007 Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 18:17-25 28. Kircher MF, Josephson L, Weissleder R 2002 Ratio imaging of enzyme activity using dual wavelength optical reporters. Mol Imaging 1:89-95
28. Funovics M, Weissleder R, Tung CH 2003 Protease sensors for bioimaging. Anal Bioanal Chem 377:956-963 30. Lee S, Cha EJ, Park K, Lee SY, Hong JK, Sun IC, Kim SY, Choi K, Kwon IC, Kim K, Ahn CH 2008 A near-infrared-fluorescencequenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew Chem Int Ed 47: 2804-2807
29. Chang E, Miller JS, Sun J, Yu WW, Colvin VL, Drezek R, West JL 2005 Protease-activated quantum dot probes. Biochem Biophys Res Commun 334:1317-1321
30. Medintz IL, Clapp AR, Mattoussi H, Goldman ER, Fisher B, Mauro JM 2003 Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater 2:630-638
31. Ye K, Schultz JS 2003 Genetic engineering of an allosterically based glucose indicator protein for continuous glucose monitoring by fluorescence resonance energy transfer. Anal Chem 75:3451-3459
32. Kim JH, Lee S, Park K, Nam HY, Jang SY, Youn I, Kim K, Jeon H, Park RW, Kim IS, Choi K, Kwon IC 2007 Protein-phosphorylationresponsive polymeric nanoparticles for imaging protein kinase activities in single living cells. Angew Chem Int Ed 46:5779-5782
33. Lee D, Khaja S, Velasquez-Castano JC, Dasari M, Sun C, Petros J, Taylor WR, Murthy N 2007 In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater 6:765-769
34. Atanasijevic T, Shusteff M, Fam P, Jasanoff A 2006 Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc Nat Acad Sci USA 103:14707-14712
35. Minchin RF, Orr RJ, Cronin AS, Puls RL 1999 The pharmacology of gene therapy. Croat Med J 40:381-391
36. Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, Linse S, Dawson KA 2007 Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 46:5754-5756
37. Labarre D, Vauthier C, Chauvierre C, Petri B, Mü ller R, Chehimi MM 2005 Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26:5075-5084
38. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA 2008 Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Nat Acad Sci USA 105:14265-14270
39. Owens 3rd DE, Peppas NA 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharmaceut 307:93-102
40. Lynch I, Dawson KA, Linse S 2006 Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006:pe14
41. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R 2002 Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317-325
42. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F,DuK, Pullar B, Lee D, Ellenbogen RG, Olson J, ZhangM2009 Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69:6200-6207
43. Islam T, Harisinghani MG 2009 Overview of nanoparticle use in cancer imaging. Cancer Biomark 5:61-67
44. Jander S, Schroeter M, Saleh A 2007 Imaging inflammation in acute brain ischemia. Stroke 38:642-645
45. Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, Fayad ZA 2008 Multimodality nanotracers for cardiovascular applications. Nat Clin Pract 5(Suppl 2):S103-S111
46. Yang L, Peng XH, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, MaoH2009 Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res 15: 4722-4732
47. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K 2009 Silica nanoparticles as hepatotoxicants. Eur J Pharmaceut Biopharmaceut 72:496-501
48. Sheng Y, Yuan Y, Liu C, Tao X, Shan X, Xu F 2009 In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. J Mater Sci 20:1881-1891
49. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S, Bentolila LA, Li J, Rao J, Chen X, Banin U, Wu AM, Sinclair R, Weiss S, Gambhir SS 2009 Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5:126-134
50. Jarrett BR, Frendo M, Vogan J, Louie AY 2007 Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging. Nanotechnology 18:35603
51. Rzigalinski BA, Strobl JS 2009 Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Applied Pharmacol 238:280-288
52. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, KirkGA 2007 Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188:586-592
53. Minchin R 2008 Nanomedicine: Sizing up targets with nanoparticles. Nat Nanotechnol 3:12-13
54. Duffin R, Tran L, Brown D, Stone V, Donaldson K 2007 Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849-856
55. Lewinski N, Colvin V, DrezekR2008 Cytotoxicity of nanoparticles. Small 4:26-49
56. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B 2006 Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346-4352
57. Dobrovolskaia MA, McNeil SE 2007 Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469-478
58. Shimada A, Kawamura N, Okajima M, Kaewamatawong T, Inoue H, Morita T 2006 Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol Pathol 34:949-957
59. Lockman PR, Koziara JM, Mumper RJ, Allen DD 2004 Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12:635-641
60. Calderó n-Garcidueñ as L,MaronpotRR,Torres-JardonR, Henríquez-Roldán C, Schoonhoven R, Acuñ a-Ayala H, Villarreal-Calderón A, Nakamura J, Fernando R, Reed W, Azzarelli B, Swenberg JA 2003 DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol Pathol 31:524-538
61. Almutairi A, Rossin R, Shokeen M, Hagody A, Ananth A, Capoccia B, Guilladean S, Abendschein D, Anderson CJ, Welch MJ, Fréchet JM 2009 Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA 106:685-690